Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (NASDAQ:
$CRON), (TSX: $ACB.TO), (TSXV: $LG.V), (TSXV: $HVT.V), (TSXV: $N.V)
Pt. Roberts, WA; Delta, BC –June 25, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast: http://www.investorideas.com/Audio/Podcasts/2018/062518-StocksToWatch.mp3
Read this in full at http://www.investorideas.com/news/2018/cannabis/06257Potcasts-NASDAQCRONTSXVACBLGHVTN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought leaders
and experts. Today’s podcast features news
announcements from Cronos Group
Inc. trading on the NASDAQ and TSX as CRON, Aurora Cannabis Inc. trading on the
TSX as ACB and the OTCQB as ACBFF, LGC
Capital Ltd. trading on the TSX-Venture as LG, Harvest One Cannabis Inc.
trading on the TSX-Venture as HVT and Namaste
Technologies Inc. trading on the TSX-Venture as N.
Cronos Group
Inc. announced that it has entered into a strategic distribution partnership
with Delfarma Sp. Zo.o ("Delfarma"). Founded in 2004, Delfarma is a
privately owned pharmaceutical wholesaler and was the first company in Poland
to introduce international parallel import of medicinal products from European
Economic Area countries. Delfarma distributes directly to over 5,000 pharmacies
and more than 200 hospitals, a distribution network that reaches approximately
40% of the Polish domestic market.
Under the
initial five-year exclusive distribution agreement, Cronos Group's global
subsidiaries will supply Peace Naturals branded cannabis products to Delfarma
for distribution within Poland. Leveraging Delfarma's extensive distribution
network, this partnership provides Cronos with unrivaled access to the Poland
market
Aurora
Cannabis Inc. announced that the Company, through its wholly owned German
subsidiary Pedanios GmbH ("Pedanios"), has become the first licensed
supplier of medical cannabis to patients in Malta. The import license issued by
the Malta Medicines Authority ("MMA") was received on June 5, 2018,
and Pedanios received the necessary export license from German authorities on
June 21, 2018. After Germany and Italy, Malta is the third European Union
member country where Pedanios currently sells medical cannabis.
LGC Capital Ltd. announced
that CLV Frontier Brands Pty Ltd (CLV), a Joint Venture between LGC, Creso
Pharma and UK based Baltic Beer Company Ltd is progressing well, with a number
of products ready for commercial launch.
·
Estonian brewing facility is complete and currently finalizing the
development of a range of CLV beers and adult soft drinks.
·
Bottling of the first two beers is expected by mid-July 2018.
·
Adult soft drinks are now in the final stage of development.
·
Brand websites preparing to go live with social media campaigns ready for
launch in the coming weeks.
·
UK portfolio launch is set for September 2018.
Harvest One
Cannabis Inc. has signed a binding Share Sale Agreement with Australian-based
MMJ PhytoTech Limited for the purchase of 100% of Israeli-based PhytoTech
Therapeutics Ltd. The transaction will be a combination of cash and shares.
Upon
completion, $1 million in cash and $7 million in Harvest One common shares
issued at the then 10-day volume weighted average closing price, will be paid
to MMJ. The sale is subject to customary conditions precedent including MMJ's
shareholder approval to be sought at a meeting at the end of August 2018.
Namaste
Technologies Inc. announced that the Company has exceeded its July 1st
goal and has acquired over 6,000 registered users on NamasteMD with a 4.9-star
rating based on 209 reviews on Apple iOS devices and a 4.7-star rating on
Google Android based on 106 consumer reviews. These results have exceeded the
Company's July 1 target of 5,000 registered users and Namaste anticipates
further acceleration of its database during the second half of the year with
new marketing initiatives and strategic partnerships including applications of
NamasteMD for Indigenous communities, targeted healthcare organizations,
digital marketing and high-traffic content networks.
NamasteMD is
Canada's first fully-integrated medical cannabis telemedicine application
available on iPhone and Android devices, which provides free consultations in
an enhanced online environment. Namaste's ability to acquire medical cannabis
patients online, with an acquisition cost of only $59.00 per patient, will
propel NamasteMD to become Canada's largest database of Canadian medical
cannabis patients.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Contact Investorideas.com
800-665-0411
